BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17062253)

  • 1. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
    Bryant AS; Pereira SJ; Miller DL; Cerfolio RJ
    Ann Thorac Surg; 2006 Nov; 82(5):1808-13; discussion 1813-4. PubMed ID: 17062253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
    Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
    Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Kobayashi T; Uno K
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):396-401. PubMed ID: 15354098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.
    Battafarano RJ; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    Ann Thorac Surg; 2002 Oct; 74(4):988-93; discussion 993-4. PubMed ID: 12400733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival and prognostic factors in resected satellite-nodule T4 non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Hu XD; Yin ZY; Jiang H; Cui Y; Gao Z; Gong M
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):120-2. PubMed ID: 19563007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.
    Kim MP; Correa AM; Hofstetter W; Mehran R; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Erasmus JJ; Swisher SG
    Ann Thorac Surg; 2015 Feb; 99(2):414-20. PubMed ID: 25497068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):151-9. PubMed ID: 15999056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage II esophageal carcinoma: the significance of T and N.
    Killinger WA; Rice TW; Adelstein DJ; Medendorp SV; Zuccaro G; Kirby TJ; Goldblum JR
    J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
    Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study.
    Lafitte JJ; Ribet ME; Prévost BM; Gosselin BH; Copin MC; Brichet AH
    Ann Thorac Surg; 1996 Sep; 62(3):830-4. PubMed ID: 8784014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does surgery have a role in T4N0 and T4N1 lung cancer?
    Chambers A; Routledge T; Billè A; Scarci M
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):473-9. PubMed ID: 20621998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.
    Kodama K; Doi O; Higashiyama M; Yokouchi H
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):347-53. PubMed ID: 9305186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
    Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
    Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
    Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.